These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Piyathilake CJ, Frost AR, Manne U, Bell WC, Weiss H, Heimburger DC, Grizzle WE. Hum Pathol; 2000 Sep; 31(9):1068-73. PubMed ID: 11014573 [Abstract] [Full Text] [Related]
6. [From dysplasia to cancer: cytologic, histopathologic and molecular aspects]. Vignaud JM. Rev Mal Respir; 1999 Jan; 16 Suppl 3():S107-11. PubMed ID: 10088273 [No Abstract] [Full Text] [Related]
7. Altered global methylation of DNA: an epigenetic difference in susceptibility for lung cancer is associated with its progression. Piyathilake CJ, Frost AR, Bell WC, Oelschlager D, Weiss H, Johanning GL, Niveleau A, Heimburger DC, Grizzle WE. Hum Pathol; 2001 Aug; 32(8):856-62. PubMed ID: 11521231 [Abstract] [Full Text] [Related]
8. [Abnormalities of molecular biology in premalignant lung lesions]. Shao SJ, Wang Y, Yang PM. Ai Zheng; 2004 Jan; 23(1):99-103. PubMed ID: 14720385 [Abstract] [Full Text] [Related]
11. Chromosome 5p aberrations are early events in lung cancer: implication of glial cell line-derived neurotrophic factor in disease progression. Garnis C, Davies JJ, Buys TP, Tsao MS, MacAulay C, Lam S, Lam WL. Oncogene; 2005 Jul 14; 24(30):4806-12. PubMed ID: 15870700 [Abstract] [Full Text] [Related]
12. Gain of 1q25-32, 12q23-24.3, and 17q12-22 facilitates tumorigenesis and progression of human squamous cell lung cancer. Ma J, Gao M, Lu Y, Feng X, Zhang J, Lin D, Xiao T, Hu Z, Yuan J, Su K, Shipley J, Xue J, Gao Y. J Pathol; 2006 Oct 14; 210(2):205-13. PubMed ID: 16927450 [Abstract] [Full Text] [Related]